Vivos Therapeutics, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
VVOS Nasdaq 3840 www.vivos.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Vivos Therapeutics, Inc.

Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association - Oct 8th, 2024 11:30 am
Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - Sep 19th, 2024 11:00 am
Vivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In Children - Sep 18th, 2024 2:05 pm
Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring - Sep 18th, 2024 11:00 am
Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update - Aug 14th, 2024 8:05 pm
Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call - Aug 14th, 2024 11:30 am
Vivos eyes human trials for radiation treatment gel with IDE submission - Jul 1st, 2024 4:33 pm
Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model - Jun 27th, 2024 11:30 am
Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance - Jun 12th, 2024 11:30 am
Consolidated Water Comments on ISS and Glass Lewis Reports and Urges Stockholders to Vote “FOR” Re-Election of Its Highly Qualified Directors - May 20th, 2024 5:04 pm
Vivos Therapeutics Inc (VVOS) Q1 2024 Earnings Call Transcript Highlights: Navigating ... - May 15th, 2024 5:01 pm
Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update - May 14th, 2024 8:05 pm
Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call - May 14th, 2024 11:30 am
Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement - Apr 9th, 2024 11:30 am
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2023 Earnings Call Transcript - Apr 1st, 2024 4:53 pm
Vivos Therapeutics Full Year 2023 Earnings: Misses Expectations - Mar 31st, 2024 12:30 pm
Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update - Mar 28th, 2024 8:05 pm
Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call - Mar 28th, 2024 11:30 am
3 Stocks to Turn $1,000 Into $1 Million: February 2024 - Feb 22nd, 2024 5:39 pm
Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross Proceeds - Feb 15th, 2024 1:00 pm